Atorvastatin and flaxseed dietary treatments improve dyslipidemia and liver injuries in a diet-induced rat model of non-alcoholic fatty liver disease.
Flaxseed therapies improved NAFLD-associated liver injuries and dyslipidemia, while atorvastatin mostly reduced hepatocyte ballooning and lobular inflammation.
Authors
- Hamidreza Joshaghani (ORCID: https://orcid.org/0000-0002-0450-2986)
- Alireza Norouzi (ORCID: https://orcid.org/0000-0003-4227-7350)
- Abdorreza Eghbal Moghanlou (ORCID: https://orcid.org/0000-0003-1238-0541)
- Seyed Javad Mirghani (ORCID: https://orcid.org/0000-0002-4846-3077)
- Zahra Eslami (ORCID: https://orcid.org/0000-0002-3187-3977)
Institutions
- Golestan University (IR)
- Golestan University of Medical Sciences (IR)
Publication Details
- Journal
- PubMed
- Published
- 2025-01-01
- DOI
- https://doi.org/10.22038/ajp.2024.25220
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Golestan University of Medical Sciences